Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Chloride, Ambenonium
2. Mytelase
1. Ambenonium Dichloride
2. 115-79-7
3. Mytelase
4. Ambenonii Chloridum
5. Ambestigmin Chloride
6. Cloruro De Ambenonio
7. Chlorure D'ambenonium
8. Ambenonium (chloride)
9. Ai3-22370
10. (oxalylbis(iminoethylene))bis((o-chlorobenzyl)diethylammonium) Dichloride
11. 51fob87g3i
12. Chebi:2628
13. Chembl1200541
14. N,n'-bis(2-diethylaminoethyl)oxamide Bis(2-chlorobenzyl Chloride)
15. Ammonium, (oxalylbis(iminoethylene))bis((o-chlorobenzyl)diethyl-, Dichloride
16. Misuran
17. Mysuran
18. Oksazil
19. Oxamizil
20. Oxazylum
21. Oxazil
22. Oxazyl
23. Dsstox_cid_2582
24. Dsstox_rid_76642
25. Dsstox_gsid_22582
26. Benzenemethanaminium, N,n'-((1,2-dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl))bis(2-chloro-n,n-diethyl-, Dichloride
27. N,n'-oxalylbis(n-2-aminoethyl-n-2-chlorobenzyldiethylammonium) Dichloride
28. (2-chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-diethylazaniumyl]ethylamino]-2-oxoacetyl]amino]ethyl]-diethylazanium;dichloride
29. Cas-115-79-7
30. Win 8077
31. Ambenonii Chloridum [inn-latin]
32. Ncgc00163221-01
33. Chlorure D'ambenonium [inn-french]
34. Cloruro De Ambenonio [inn-spanish]
35. Einecs 204-107-5
36. Unii-51fob87g3i
37. Mytelase (tn)
38. Ambenonium Chloride [usp:inn:ban:jan]
39. N,n'-bis(2-diethylaminoethyl)oxamid Bis-2-chlorbenzyl Chlorid
40. (oxalylbis(iminoethylen))bis(2-chlorbenzyl)diethylammonium Chlorid)
41. Schembl133487
42. Ambenonium Chloride [mi]
43. Dtxsid3022582
44. Ambenonium Chloride [inn]
45. Ambenonium Chloride [jan]
46. Ambenonium Chloride (jp17/inn)
47. Hms3266k15
48. Hms3414f07
49. Hms3678f07
50. Ambenonium Chloride [vandf]
51. Tox21_112030
52. Ambenonium Chloride [who-dd]
53. Akos024457845
54. Tox21_112030_1
55. Ambenonium Chloride [orange Book]
56. Ncgc00024567-03
57. Hy-100919
58. B6286
59. Cs-0020589
60. D01001
61. Sr-01000597958
62. Sr-01000597958-1
63. Q27105751
64. 2,2'-[(1,2-dioxoethane-1,2-diyl)diimino]bis[n-(2-chlorobenzyl)-n,n-diethylethanaminium] Dichloride
65. 2,2'-[(1,2-dioxoethane-1,2-diyl)diimino]bis{n-[(2-chlorophenyl)methyl]-n,n-diethylethanaminium} Dichloride
66. N,n'-[(1,2-dioxo-1,2-ethanediyl)bis( Imino-2,1-ethanediyl)]bis(2-chloro-n,n-diethylbenz Enemethaminium) Dichloride
67. N,n'-[(1,2-dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl)]bis(2-chloro-n,n-diethylbenzenemethaminium) Dichloride
| Molecular Weight | 608.5 g/mol |
|---|---|
| Molecular Formula | C28H42Cl4N4O2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 14 |
| Exact Mass | 608.203237 g/mol |
| Monoisotopic Mass | 606.206187 g/mol |
| Topological Polar Surface Area | 58.2 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 614 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Parasympathomimetics
Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (See all compounds classified as Parasympathomimetics.)
Cholinesterase Inhibitors
Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. (See all compounds classified as Cholinesterase Inhibitors.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Data currently not available.
Ask PharmaCompass should you need more information on this topic.
Listed Suppliers
About the Company : Established in 1984, R L Fine Chem Pvt. Ltd. is one of the fastest growing API companies, with a leadership position in several APIs such as antihistamines, antidepressants and mus...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MYTELASE
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 1982-01-01
Application Number : 10155
Regulatory Info : DISCN
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Sweden
Brand Name : Mytelase
Dosage Form : TABLETT
Dosage Strength : 10 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RLD : No
TE Code :
Brand Name : MYTELASE
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Approval Date : 1982-01-01
Application Number : 10155
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Sweden
Brand Name : Mytelase
Dosage Form : TABLETT
Dosage Strength : 10 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
Market Place
